Veracyte to Present at the UBS Global Healthcare Conference
May 09 2019 - 4:20PM
Business Wire
Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics
company, today announced that Bonnie H. Anderson, chairman and
chief executive officer, is scheduled to present at the UBS Global
Healthcare Conference in New York City on Monday, May 20,
2019 at 9:30 a.m. EDT.
The link to the live audio webcast of the company’s presentation
will be available by visiting Veracyte’s website at
http://investor.veracyte.com/events-presentations. A replay of the
webcast will be available for 90 days following the conclusion of
the live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a leading genomic diagnostics company
that improves patient care by providing trustworthy and actionable
answers to challenging clinical questions. The company's products
uniquely combine advanced genomic technology, clinical science and
machine learning to provide answers that give physicians and
patients a clear path forward, informing both diagnosis and
treatment decisions without the need for costly, risky surgeries
that are often unnecessary. Since its founding in 2008, Veracyte
has commercialized five genomic tests which are transforming the
diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary
fibrosis. Veracyte is based in South San Francisco, California. For
more information, please visit www.veracyte.com and follow the
company on Twitter (@veracyte).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190509005849/en/
Veracyte Investor & Media Contact:Angie McCabeVice
President, Investor Relations & Corporate
Communications650-243-6371angie@veracyte.com
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Sep 2023 to Sep 2024